Hold Sun Pharmaceutical Industries target of Rs 460: Sharekhan
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated November 13, 2019.
November 14, 2019 / 11:43 AM IST
Sharekhan's research report on Sun Pharmaceutical Industries
Sun Pharma’s Q2FY2020 results are in line with estimates. Staggered penetration of specialty portfolio, higher specialty promotional spends, increasing R&D, and continued pricing issues in the U.S. are likely to be the key challenge for earnings growth We expect the company to report sales and profit CAGR of 14% and 22%, respectively, over the next two years.
We maintain Hold rating on Sun Pharma with a revised PT of Rs 460.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.